Jennie Mcgregor, Sanofi, US

Jennie Mcgregor, Sanofi, US

Patient Engagement

Continuously improving how we collaborate and communicate with the patient community.

Alizée’s father standing behind his wife and Alizee Agier, a women with Type 1 Diabetes who are seated at a table in a home setting.
Alizée Agier and her parents, Type 1 Diabetes, France

The Integrated Patient Engagement Model at Sanofi

Patient centricity is not enough. At Sanofi we do not work for patients, we work with them. We are constantly improving how we engage and communicate with the patient community, and strive in all functions and at every stage to respect the patient community as equal partners.

Anise, a woman living with a rare blood disorder, walks down the street with her mother. They exchange a warm glance, clearly enjoying their time together
Anise and her Mother,  Acquired Thrombotic Thrombocytopenia Purpura (Attp),  USA

Our Patient Community Promise

In 2023 we launched the Sanofi Patient Community Promise, a set of commitments and measurements developed with input from over 80 patient and caregiver organizations worldwide and endorsed by the Sanofi Executive Committee. The Promise is organized across the life cycle of a product and includes addressing gaps in the broader healthcare ecosystem with respect to more deeply embedding patient voice and our accountability in this regard.

Reporting on our Promise

To ensure both external transparency and internal accountability our Promise was written to include measurement, or metrics, of how well we live up to our commitments. These have been refined over the last year as we worked across Sanofi to develop new tools to capture data and to ensure we were not redundant in the data we captured.   

2024 is the first year from which we will report- more to come soon!

Equal Partner

Actions speak louder than words. See below innovative ways we are partnering with the patient community to drive real progress.  

Miwako a woman living with an immunology disease smiling at the camera while her daughter kisses her on the cheek in a park-like setting.
The Chronic Ordinary Pulmonary Disease (COPD) Map

The COPD Patient Care Map is an innovative educational and advocacy tool co-created by the Global Allergy and Airways Patient Platform, the European Federation of Allergy and Airways Diseases Patient Associations, the Chronic Ordinary Pulmonary Disease Foundation, Sanofi, Regeneron, and Alira Health and shaped by nine global patient advocacy groups. It highlights the challenges faced by COPD patients and caregivers, bridging the gap between experiences and policy action, and fostering collaboration to drive lasting solutions.

Our Clinical Trials

Explore Sanofi’s clinical trials hub, packed with resources for the patient community. Discover details about ongoing studies, trial results, and our commitment to clinical trial diversity. Use the tools available to understand the research process, access global clinical trial registries, and find out how to get involved.

Supporting Patient Communities

A strong and inclusive patient community is vital in creative effective health policy and systems.  Sanofi leads a number of projects to ensure patient communities have a strong and independent ecosystem that allows them to operate with credibility and impact.

Capability Buildings Programs: Building Local Community

We believe in empowering patients to amplify their voice in healthcare. Partnering with United Patients, we conduct hands on training in emerging and developing markets, bringing tools, resources, and a network of experts to these patient communities.

A Million Conversations

A Million Conversations is Sanofi’s global initiative to build trust in healthcare in particular for underrepresented groups: women, people with disabilities, people from ethnic minority groups and people who identified as LGBTQ+. 

Sustainable and Equitable Access to Healthcare

Health inequalities remain high globally, especially in areas affected by climate change. Barriers to access include lack of awareness, weak healthcare capabilities, and political challenges. Our goal is to address these issues, ensuring sustainable and equitable patient access to healthcare through comprehensive care programs and collaboration with local patients and stakeholders and healthcare systems. 

Ensuring Patients Take Medicines Safely

We have evolved pharmacovigilance from a purely risk-focused approach to a science-risk balance. We use detailed insights to better understand how medicines perform in the real world, providing invaluable information to the communities we serve.

Taking Medicines Safely
Patient Safety at Sanofi